Rigel Pharmaceuticals أخبار Eulerpool

Rigel Pharmaceuticals إيولربول AFX

أخبار سهم Rigel Pharmaceuticals

يتابع Rigel Pharmaceuticals العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Rigel Pharmaceuticals.

• ١٢ سبتمبر ·

  Yahoo
  Rigel to Present at the 2024 Cantor Global Healthcare Conference
• ٦ سبتمبر ·

  Yahoo
  Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
• ٥ سبتمبر ·

  Yahoo
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
• ٥ سبتمبر ·

  PR Newswire
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA? (olutasidenib) in mIDH1 AML
• ٥ سبتمبر ·

  Thefly.com
  Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial
• ٣ سبتمبر ·

  Yahoo
  Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
• ٣ سبتمبر ·

  TipRanks
  Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation
• ٣ سبتمبر ·

  PR Newswire
  Rigel Expands Relationship with Kissei to include REZLIDHIA? (olutasidenib) in Japan, the Republic of Korea and Taiwan
• ٣ سبتمبر ·

  Thefly.com
  Rigel Pharmaceuticals enters license and supply agreement with Kissei Pharma
• ٢٩ أغسطس ·

  Yahoo
  With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest